Home Home Contact Us Help Registering and Participating Disclaimer Please Note: THIS FORUM IS PATIENT MODERATED AND IS NOT CONNECTED TO ANY CLINIC OR DOCTOR. IF YOU WISH TO CONTACT A CERTAIN DOCTOR OR CLINIC, PLEASE LOOK IN THE ASK THE DOCTOR SECTION FOR DOCTOR OR CLINIC PHONE NUMBERS AND EMAIL ADDRESSES.

                       Home || Contact Us || Help Registering and Participating || Disclaimer

Unlock Secrets in Your Own DNA with 23andMe.com

Nutri-Health Products

 Buy 1 Get 1 Free at Puritan's Pride

LivLong – The Ultimate Anti-aging Product

SeaChange Partners with Life Extension Products

 

Barbara and Jeannine's Book

Bea Luis Memorial

 

Join the ICMS


Go Back   Stem Cell Pioneers > Meeting Hall > General Discussion
Register Blogs FAQ Members List Social Groups Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Search this Thread Display Modes
  #1  
Old 08-26-2009, 03:38 PM
barbara barbara is offline
Pioneer Founding member
 
Join Date: May 2007
Posts: 6,892
Blog Entries: 5
Default Dr. Collins Reveals His Plans for the NIH

I would urge each and everyone of you to contact Dr. Collins at the NIH and respectfully encourage him to include more stem cell research in his plans.

Dr. Collins Reveals His Plans

In an August 17 address to NIH, its new director, Francis S. Collins, M.D., Ph.D., emphasized five themes he will devote his energies to:

* Apply high-throughput technologies to understand fundamental biology and uncover the causes of disease, allowing scientists to tackle problems in a comprehensive way.
* Support translational research to take advantage of new discoveries that can lead to new diagnostics and treatments. This includes getting academic investigators more involved and creating more public-private partnerships.
* Put scientists to work to benefit health care reform, including a focus on comparative effectiveness research, behavioral science, and health disparities.
* Expand global health efforts beyond AIDS, tuberculosis, and malaria, and build research capacity in resource-poor environments.
* Invigorate and empower the research community by ensuring stable funding, strengthening training programs, encouraging new investigators, promoting diversity in the workforce, and supporting the NIH Common Fund.

Dr. Collins also shared his concerns. Foremost is a reprise of the funding shortfall that occurred after the doubling of the NIH budget ended in 2003, a dire possibility for 2011 when ARRA funds end.

Feast or famine is bad for science, he said, and highlighted the need to make the case that NIH-supported research is good for the economy and beneficial to the public. In that vein, scientists should become major players in CER, and the scientific community should figure out how to help contain health care costs.
__________________
First treatment in 2007. Pioneering ever since.

Barbara
Reply With Quote
  #2  
Old 08-26-2009, 07:30 PM
Jeannine Jeannine is offline
Pioneer Founding member
 
Join Date: May 2007
Location: New Hampshire
Posts: 1,655
Blog Entries: 1
Default

I don't see much in his plans that is in the interest of Americans with chronic illneses. I don't think we have much trouble with malaria or tuberculosis in the US and I don't see how diversity in the workforce wiil find cures either. If this is the NATIONAL Institute of Health why do his plans sound GLOBAL?

Unfortunately, he sounds like a typical government bureaucrat.
__________________
Still Pioneering
Had UC treatment April 5th, 2007
Had autologous treatment March 19, 2010
Had bone marrow and adipose stem cell treatment (autologous) June 16, 2010
Reply With Quote
  #3  
Old 08-28-2009, 10:41 AM
barbara barbara is offline
Pioneer Founding member
 
Join Date: May 2007
Posts: 6,892
Blog Entries: 5
Default

Good points Jeannine. Here's another interesting bit of correspondence I ran across sent in 2007! Soon, it will be 2010. It is easy to see how estimates of 10-20+ years are going to be a reality for treatments to become available.

Stem cells: Current challenges and future promise
James F. Battey *
National Institutes of Health, Bethesda, Maryland
email: James F. Battey (batteyj@nidcd.nih.gov)

*Correspondence to James F. Battey, NIH Bldg. 31, Rm 3C02, 9000 Rockville Pike, Bethesda, MD 20892-2320
This article is a US Government work and, as such, is in the public domain in the United States of America.


Abstract
Stem cells have two remarkable properties. They can either renew themselves or they can differentiate into one or more adult cell types. Stem cells derived from a human embryo appear to have an unlimited capacity to self-renew in cell culture, and they are also able to differentiate into hundreds of adult cell types. Human embryonic stem cell lines offer a platform technology that has the potential to elucidate the molecular mechanisms that determine adult cell fate, generate cellular models for discovery of new drugs, and create populations of differentiated cells for novel transplantation therapies. The National Institutes of Health (NIH) has identified some of the rate-limiting steps toward realizing this potential, and has forged funding initiatives to accelerate research progress. Given the remarkable potential, NIH support for research using stem cells is an important priority for the foreseeable future. Developmental Dynamics 236:3193-3198, 2007. Published 2007 Wiley-Liss, Inc.
Accepted: 19 April 2007
__________________
First treatment in 2007. Pioneering ever since.

Barbara
Reply With Quote
Reply

Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump

Copyright 2007 - 2011 Stem Cell Pioneers


All times are GMT -6. The time now is 02:09 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2013, vBulletin Solutions, Inc.
Stem Cell Pioneers